Carboplatin 50mg/5 mL
Product Overview
| Generic Name | Carboplatin 50mg/5 mL |
| Brand Name(s) | Carbokem (Alkem) |
| Category | Antineoplastic / Cancer |
| Form | Injectable, multiple-dose vial |
| Strength | 50 mg in 5 mL (10 mg/mL) |
| Therapeutic Class | Platinum-based alkylating agent |
| ATC Code | L01XA02 |
Manufacturing & Regulatory
| Manufacturer | Alkem Laboratories Ltd |
| GMP Compliance | WHO |
| DMF/CEP | Available; manufacturer-specific DMF/USDMF |
| COFEPRIS | Under Registration (2025) |
| Free Sale Certificate | per batch upon request |
Logistics & Export
| MOQ | 10 Vials |
| Shelf Life | 36 months |
| Storage | 20–25 °C, protect from light; do not freeze |
| Incoterms | EXW/FOB/CIF negotiable |
| Lead Time | 10 Days |
Documentation Available Upon Request
| Certificate of Analysis (PDF) | Provided per batch |
| SDS-Safety Data Sheet (PDF) | Available from manufacturer |
| CTD Summary (PDF) | Full CTD for originator; generics hold abbreviated dossiers |
Special Notes
Indications & Usage Advanced ovarian cancer, small‑cell lung cancer, other solid tumors